|
1
|
Tanaka K, Ishihara T, Azuma A, Kudoh S,
Ebina M, Nukiwa T, Sugiyama Y, Tasaka Y, Namba T, Ishihara T, Sato
K, Mizushima Y and Mizushima T: Therapeutic effect of lecithinized
superoxide dismutase on bleomycin-induced pulmonary fibrosis. Am J
Physiol Lung Cell Mol Hysiol. 298:L348–L360. 2010. View Article : Google Scholar
|
|
2
|
Raghu G, Collard HR, Egan JJ, Martinez FJ,
Behr J, et al: ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary
Fibrosis: An official ATS/ERS/JRS/ALAT statement: Idiopathic
pulmonary fibrosis: Evidence-based guidelines for diagnosis and
management. Am J Respir Crit Care Med. 183:788–824. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma
YG, Wang XX, Liu HZ, Sun W and Hu ZW: Blocking IL-17A promotes the
resolution of pulmonary inflammation and fibrosis via TGF-beta
1-dependent and -independent mechanisms. J Immunol. 187:3003–3014.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Umezawa H, Maeda K, Takeuchi T and Okami
Y: New antibiotics, bleomycin A and B. J Antibiot (Tokyo).
19:200–209. 1966.PubMed/NCBI
|
|
5
|
Hoshino T, Okamoto M, Sakazaki Y, Kato S,
Young HA and Aizawa H: Role of proinflammatory cytokines IL-18 and
IL-1beta in bleomycin-induced lung injury in humans and mice. Am J
Respir Cell Mol Biol. 41:661–670. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang CL, Wang WJ, Zhu HL, Fan XM, Chen
JP, Zhan XQ and Li YY: Effect of andrographolide on expression of
hydroxyproline and PDGF in lung tissue of bleomycin-induced rat
pulmonary fibrosis. Shizhen Guo Yi Guo Yao. 23:904–907. 2012.(In
Chinese).
|
|
7
|
Huang C, Li Y, Fan X, Wang W and Zhan X:
Effects of combination of Salvia and Ligustrazine on TNF-α and
TGF-β1 in serum and BALF of rats with pulmonary fibrosis. Xi Bao Yu
Fen Zi Mian Yi Xue Za Zhi. 29:673–676. 2013.(In Chinese).
PubMed/NCBI
|
|
8
|
Tabata C, Kubo H, Tabata R, Wada M, Sakuma
K, Ichikawa M, Fujita S, Mio T and Mishima M: All-trans retinoic
acid modulates radiation-induced proliferation of lung fibroblasts
via IL-6/IL-6R system. Am J Physiol Lung Cell Mol Physiol.
290:L597–L606. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee KY, Ito K, Hayashi R, Jazrawi EP,
Barnes PJ and Adcock M: NF-kappa B and activator protein 1 response
elements and the role of histone modifications in IL-1 beta-induced
TGF-beta 1 gene transcription. J Immunol. 176:603–615. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu JP, Di NL, Fan XM, Li SC and Zhang SP:
The expressions of STAT1 and PDGF in lung tissue of rats with
pulmonary fibrosis induced by bleomycin. Shan Dong Yi Yao.
31:16–18. 2008.(In Chinese).
|
|
11
|
Halwani R, Al-Muhsen S and Hamid Q: T
helper 17 cells in airway diseases: From laboratory bench to
bedside. Chest. 143:494–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Truchetet ME, Mossalayi MD and Boniface K:
IL-17 in the rheumatologist's line of sight. Biomed Res Int.
2013:2951322013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baeten D, Baraliakos X, Braun J, Sieper J,
Emery P, et al: Anti-interleukin-17A monoclonal antibody
secukinumab in treatment of ankylosing spondylitis: A randomised,
double-blind, placebo-controlled trial. Lancet. 382:1705–1713.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leonardi C, Matheson R, Zachariae C,
Cameron G, Li L, Edson-Heredia E, Braun D and Banerjee S:
Anti-interleukin-17 monoclonal antibody ixekizumab in chronic
plaque psoriasis. N Engl J Med. 366:1190–1199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papp KA, Leonardi C, Menter A, Ortonne JP,
Krueger JG, Kricorian G, Aras G, Li J, Russell CB, Thompson EH and
Baumgartner S: Brodalumab, an anti-interleukin-17-receptor antibody
for psoriasis. N Engl J Med. 366:1181–1189. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wilson MS, Madala SK, Ramalingam TR,
Gochuico BR, Rosas IO, Cheever AW and Wynn TA: Bleomycin and
IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med.
207:535–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gasse P, Riteau N, Vacher R, Michel ML,
Fautrel A, di Padova F, Fick L, Charron S, Lagente V, Eberl G, Le
Bert M, Quesniaux VF, Huaux F, Leite-de-Moraes M, Ryffel B and
Couillin I: IL-1 and IL-23 mediate early IL-17A production in
pulmonary inflammation leading to late fibrosis. PLoS One.
6:e231852011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu H, Li Z, Lv XX and Mi S:
Neutralization of IL-17A activity can improve pulmonary function in
mice with pulmonary fibrosis. Hang Tian Yi Xue Yu Yi Xue Gong
Cheng. 26:38–42. 2013.(In Chinese).
|
|
19
|
Fan XM, Zhang SB, Liu CT, Xiong B and Wang
ZL: STAT1 antisense oligonucleotides inhibit secretion of
TNF-alpha, IL-8 and NO in alveolar macrophages of rats suffering
from interstitial pulmonary fibrosis. Xi Bao Yu Fen Zi Mian Yi Xue
Za Zhi. 22:487–489. 2006.(In Chinese). PubMed/NCBI
|
